Ertel Monica K, Kahook Malik Y, Capitena Young Cara E
Sue Anschutz-Rodgers Eye Center, UC Health, University of Colorado, Aurora, CO USA.
Curr Ophthalmol Rep. 2021;9(3):88-95. doi: 10.1007/s40135-021-00269-x. Epub 2021 Jul 7.
The field of teleglaucoma has expanded rapidly in recent years with several large-scale teleglaucoma screening programs in existence throughout the world. Additionally, teleglaucoma programs for use in disease management are under study. The limited access to care that resulted from the COVID-19 pandemic highlighted the need for expansion of such programs. This article reviews the literature on teleglaucoma for screening and management of glaucoma, discussing considerations for incorporating teleglaucoma into clinical practice.
Teleglaucoma screening reduces the rate of false-positive referrals and can accurately screen at-risk populations with accuracy similar to in-person screening. The use of teleglaucoma for the management of glaucoma shows promise for low-risk patients with early disease. Furthermore, teleglaucoma is cost-effective and reduces travel burden for patients resulting in high patient satisfaction.
Teleglaucoma offers potential for improving access to glaucoma care, reducing the burden on patients and health care systems.
近年来，远程青光眼领域发展迅速，全球有多个大规模的远程青光眼筛查项目。此外，用于疾病管理的远程青光眼项目也在研究中。2019年冠状病毒病大流行导致的医疗服务可及性受限凸显了扩大此类项目的必要性。本文回顾了关于远程青光眼用于青光眼筛查和管理的文献，讨论了将远程青光眼纳入临床实践的注意事项。
远程青光眼筛查可降低假阳性转诊率，并且能够准确筛查高危人群，其准确性与面对面筛查相似。将远程青光眼用于青光眼管理，对患有早期疾病的低风险患者显示出前景。此外，远程青光眼具有成本效益，减轻了患者的出行负担，患者满意度很高。
远程青光眼有望改善青光眼医疗服务的可及性，减轻患者和医疗系统的负担。
